M
The startup develops treatments for metabolic diseases by utilizing technology to reduce advanced glycation endproducts (AGEs), which are harmful sugar toxins. This approach enables the creation of customized medical foods tailored to individual patient needs through consultations at hospitals, clinics, and pharmacies.
Suwon, South Korea
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops treatments for metabolic diseases by utilizing technology to reduce advanced glycation endproducts (AGEs), which are harmful sugar toxins. This approach enables the creation of customized medical foods tailored to individual patient needs through consultations at hospitals, clinics, and pharmacies.